Monocyte Distribution Width (MDW) is a new generation cell blood count parameter providing a measure of monocyte anisocytosis. In the last decades, it has emerged as a reliable biomarker of sepsis in the acute setting, especially emergency department, and intensive care unit. MDW has several advantages over commonly used sepsis biomarkers, including low-cost, ease and speed of measurement. The clinical usefulness of MDW has been established in several studies and some clinical laboratory medicines have already implemented it in their routine. In this article, we describe the analytical and clinical features of MDW to guide its appropriate use in clinical practice by integrating the research evidence with real-world laboratory experience. The proper use of a biomarker is critical for improving patients' care and outcome as well as ensuring healthcare quality.

Ciaccio, A.M., Agnello, L., Sasso, B.L., Giglio, R.V., Iacona, A., Gambino, C.M., et al. (2023). Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach [10.1016/j.cca.2022.117214].

Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach

Ciaccio, Anna Maria
Primo
;
Agnello, Luisa;Sasso, Bruna Lo;Giglio, Rosaria Vincenza;Iacona, Alessandro;Gambino, Caterina Maria;Scazzone, Concetta;Tuttolomondo, Antonino;Ciaccio, Marcello
Ultimo
2023-02-01

Abstract

Monocyte Distribution Width (MDW) is a new generation cell blood count parameter providing a measure of monocyte anisocytosis. In the last decades, it has emerged as a reliable biomarker of sepsis in the acute setting, especially emergency department, and intensive care unit. MDW has several advantages over commonly used sepsis biomarkers, including low-cost, ease and speed of measurement. The clinical usefulness of MDW has been established in several studies and some clinical laboratory medicines have already implemented it in their routine. In this article, we describe the analytical and clinical features of MDW to guide its appropriate use in clinical practice by integrating the research evidence with real-world laboratory experience. The proper use of a biomarker is critical for improving patients' care and outcome as well as ensuring healthcare quality.
1-feb-2023
Ciaccio, A.M., Agnello, L., Sasso, B.L., Giglio, R.V., Iacona, A., Gambino, C.M., et al. (2023). Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach [10.1016/j.cca.2022.117214].
File in questo prodotto:
File Dimensione Formato  
Monocyte Distribution Width (MDW) as a biomarker of sepsis- An evidenced-based laboratory medicine approach.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 4.65 MB
Formato Adobe PDF
4.65 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/582277
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact